| Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP2C19 and Voriconazole Therapy B Moriyama, AO Obeng, J Barbarino, SR Penzak, SA Henning, SA Scott, ... Clinical Pharmacology & Therapeutics 102 (1), 45-51, 2017 | 354 | 2017 |
| Clinical pharmacogenetics implementation: approaches, successes, and challenges KW Weitzel, AR Elsey, TY Langaee, B Burkley, DR Nessl, AO Obeng, ... American Journal of Medical Genetics Part C: Seminars in Medical Genetics …, 2014 | 197 | 2014 |
| Genetic variation among 82 pharmacogenes: the PGRNseq data from the eMERGE network WS Bush, DR Crosslin, A Owusu‐Obeng, J Wallace, B Almoguera, ... Clinical Pharmacology & Therapeutics 100 (2), 160-169, 2016 | 188 | 2016 |
| Review of opioid pharmacogenetics and considerations for pain management A Owusu Obeng, I Hamadeh, M Smith Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 37 (9 …, 2017 | 174 | 2017 |
| CYP2C19 Polymorphisms and Therapeutic Drug Monitoring of Voriconazole: Are We Ready for Clinical Implementation of Pharmacogenomics? A Owusu Obeng, EF Egelund, A Alsultan, CA Peloquin, JA Johnson Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 34 (7 …, 2014 | 144 | 2014 |
| Implementation and utilization of genetic testing in personalized medicine NS Abul-Husn, A Owusu Obeng, SC Sanderson, O Gottesman, SA Scott Pharmacogenomics and personalized medicine, 227-240, 2014 | 132 | 2014 |
| Emerging roles for pharmacists in clinical implementation of pharmacogenomics A Owusu‐Obeng, KW Weitzel, RC Hatton, BJ Staley, J Ashton, ... Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 34 (10 …, 2014 | 128 | 2014 |
| Physician-reported benefits and barriers to clinical implementation of genomic medicine: a multi-site IGNITE-network survey A Owusu Obeng, K Fei, KD Levy, AR Elsey, TI Pollin, AH Ramirez, ... Journal of personalized medicine 8 (3), 24, 2018 | 122 | 2018 |
| Multisite Investigation of Strategies for the Implementation of CYP2C19 Genotype‐Guided Antiplatelet Therapy PE Empey, JM Stevenson, S Tuteja, KW Weitzel, DJ Angiolillo, ... Clinical Pharmacology & Therapeutics 104 (4), 664-674, 2018 | 117 | 2018 |
| Harmonizing clinical sequencing and interpretation for the eMERGE III network H Zouk, E Venner, NJ Lennon, DM Muzny, D Abrams, S Adunyah, ... The American Journal of Human Genetics 105 (3), 588-605, 2019 | 93 | 2019 |
| The IGNITE Pharmacogenetics Working Group: an opportunity for building evidence with pharmacogenetic implementation in a real‐world setting LH Cavallari, AL Beitelshees, KV Blake, LG Dressler, JD Duarte, A Elsey, ... Clinical and translational science 10 (3), 143, 2017 | 92 | 2017 |
| Views of primary care providers on testing patients for genetic risks for common chronic diseases D Hauser, AO Obeng, K Fei, MA Ramos, CR Horowitz Health Affairs 37 (5), 793-800, 2018 | 81 | 2018 |
| Antiplatelet drug interactions with proton pump inhibitors SA Scott, A Owusu Obeng, JS Hulot Expert opinion on drug metabolism & toxicology 10 (2), 175-189, 2014 | 69 | 2014 |
| Knowledge and attitudes on pharmacogenetics among pediatricians S Rahawi, H Naik, KV Blake, A Owusu Obeng, RM Wasserman, Y Seki, ... Journal of human genetics 65 (5), 437-444, 2020 | 67 | 2020 |
| Multi-site investigation of strategies for the clinical implementation of CYP2D6 genotyping to guide drug prescribing LH Cavallari, SL Van Driest, CA Prows, JR Bishop, NA Limdi, VM Pratt, ... Genetics in Medicine 21 (10), 2255-2263, 2019 | 61 | 2019 |
| Physician attitudes toward adopting genome-guided prescribing through clinical decision support CL Overby, AL Erwin, NS Abul-Husn, SB Ellis, SA Scott, AO Obeng, ... Journal of personalized medicine 4 (1), 35-49, 2014 | 57 | 2014 |
| A pharmacogenomics clinical decision support service based on FHIR and CDS hooks RH Dolin, A Boxwala, J Shalaby Methods of information in medicine 57 (S 02), e115-e123, 2018 | 51 | 2018 |
| Prescribing prevalence of medications with potential genotype-guided dosing in pediatric patients LB Ramsey, HH Ong, JS Schildcrout, Y Shi, LA Tang, JK Hicks, ... JAMA network open 3 (12), e2029411-e2029411, 2020 | 41 | 2020 |
| Pharmacogenomics implementation: considerations for selecting a reference laboratory TT Vo, GC Bell, A Owusu Obeng, JK Hicks, HM Dunnenberger Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 37 (9 …, 2017 | 40 | 2017 |
| Multisite investigation of strategies for the clinical implementation of pre-emptive pharmacogenetic testing JD Duarte, R Dalton, AL Elchynski, DM Smith, EJ Cicali, JC Lee, ... Genetics in Medicine 23 (12), 2335-2341, 2021 | 39 | 2021 |
